PharmaJet (R) , a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...
PharmaJet's Needle-free Tropis is being evaluated in a clinical study by REDE-TB as a potential improvement on the TB skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results